VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 56 of Oncotarget features Figure 1A, "Selinexor reduces the expression of DDR proteins ," by Kashyap, et al.
|
|
Table of Contents
Research Papers
|
| Etidronate prevents but does not reverse ectopic mineralization in a mouse model of pseudoxanthoma elasticum Abcc6−/− |
|
https://doi.org/10.18632/oncotarget.10738
|
| 30721-30730 |
|
| Systematic verification of bladder cancerassociated tissue protein biomarker candidates in clinical urine specimens |
|
https://doi.org/10.18632/oncotarget.24578
|
| 30731-30747 |
|
| PM25 induced cardiac hypertrophy via CREB/GSK3b/SOS1 pathway and metabolomics alterations |
|
https://doi.org/10.18632/oncotarget.25479
|
| 30748-30760 |
|
| NGAL promotes recruitment of tumor infiltrating leukocytes |
|
https://doi.org/10.18632/oncotarget.25625
|
| 30761-30772 |
|
| Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents |
|
https://doi.org/10.18632/oncotarget.25637
|
| 30773-30786 |
|
| Autophagydependent apoptosis is triggered by a semisynthetic [6]gingerol analogue in triple negative breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25704
|
| 30787-30804 |
|
| Mebendazole stimulates CD14+ myeloid cells to enhance Tcell activation and tumour cell killing |
|
https://doi.org/10.18632/oncotarget.25713
|
| 30805-30813 |
|
| Cell based functional assays for IDO1 inhibitor screening and characterization |
|
https://doi.org/10.18632/oncotarget.25720
|
| 30814-30820 |
|
| Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25738
|
| 30821-30836 |
|
| Chloroquine plays a celldependent role in the response to treatment of pancreatic adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.25745
|
| 30837-30846 |
|
| Intratumoral immunebiomarkers and mismatch repair status in leiyomyosarcoma potential predictive markers for adjuvant treatment: a pilot study |
|
https://doi.org/10.18632/oncotarget.25747
|
| 30847-30854 |
|
| Influence of age on radiomic features in 18FFDG PET in normal breast tissue and in breast cancer tumors |
|
https://doi.org/10.18632/oncotarget.25762
|
| 30855-30868 |
|
| Applied diagnostics in liver cancer Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR |
|
https://doi.org/10.18632/oncotarget.25766
|
| 30869-30882 |
|
| Association between genetic polymorphisms and platinuminduced ototoxicity in children |
|
https://doi.org/10.18632/oncotarget.25767
|
| 30883-30893 |
|
| ST2/IL33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate |
|
https://doi.org/10.18632/oncotarget.25768
|
| 30894-30904 |
|
| Stemlike and highly invasive prostate cancer cells expressing CD44v810 marker originate from CD44negative cells |
|
https://doi.org/10.18632/oncotarget.25773
|
| 30905-30918 |
|
| Protection from chemotherapy and antibioticmediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement |
|
https://doi.org/10.18632/oncotarget.25778
|
| 30919-30935 |
Corrections
|
| Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes |
|
https://doi.org/10.18632/oncotarget.25856
|
| 30936-30936 |
|
| Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis |
|
https://doi.org/10.18632/oncotarget.25857
|
| 30937-30937 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
